Patents by Inventor Markus Eickmann

Markus Eickmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
    Patent number: 7135186
    Abstract: Varicella zoster virus (VZV) inimunoreactive protein VP26 and its diagnostic use are described. The invention relates to immunoreactive peptides which are homologous with the region of amino acid positions 12 to 235 (SEQ ID NO: 7) of the varicella zoster virus protein VP26, to nucleic acids which encode these peptides and to the use of the peptides or nucleic acids for diagnosing an infection with varicella zoster virus.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: November 14, 2006
    Assignee: Dade Behring Marburg GmbH
    Inventors: Markus Eickmann, Dorothee Gicklhorn, Klaus Radsak, Hans-Peter Hauser, Bernhard Giesendorf
  • Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)
    Patent number: 6960442
    Abstract: The present invention relates to immunoreactive peptides that are homologous with the region encompassing amino acid positions 450 to 655 of glycoprotein II of varicella zoster virus. In this context, preference is given to those peptides corresponding to segments of amino acids 505 to 647, 517 to 597, 535 to 584 or 545 to 582. The immunoreactive peptides are useful for methods of diagnosing varicella zoster virus infection.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: November 1, 2005
    Assignee: Dade Behring Marburg GmbH
    Inventors: Markus Eickmann, Dorothee Gicklhorn, Klaus Radsak, Hans-Peter Hauser, Bernhard Giesendorf
  • Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
    Publication number: 20050202413
    Abstract: Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use are described. The invention relates to immunoreactive peptides which are homologous with the region of amino acid positions 12 to 235 of the varicella zoster virus protein VP26, to nucleic acids which encode these peptides and to the use of the peptides or nucleic acids for diagnosing an infection with varicella zoster virus.
    Type: Application
    Filed: June 6, 2001
    Publication date: September 15, 2005
    Inventors: Markus Eickmann, Dorothee Gicklhorn, Klaus Radsak, Hans-Peter Hauser, Bernhard Giesendorf
  • Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)
    Publication number: 20020150889
    Abstract: The present invention relates to immunoreactive peptides that are homologous with the region encompassing amino acid positions 450 to 655 of glycoprotein II of varicella zoster virus. In this context, preference is given to those peptides corresponding to segments of amino acids 505 to 647, 517 to 597, 535 to 584 or 545 to 582. The immunoreactive peptides are useful for methods of diagnosing varicella zoster virus infection.
    Type: Application
    Filed: April 23, 2002
    Publication date: October 17, 2002
    Inventors: Markus Eickmann, Dorothee Gicklhorn, Klaus Radsak, Hans-Peter Hauser, Bernhard Giesendorf
  • Immunoreactive regions of glycoprotein GPII of varicella zoster virus
    Patent number: 6414116
    Abstract: The present invention relates to immunoreactive peptides that are homologous with the region encompassing amino acid positions 450 to 655 of glycoprotein II of varicella zoster virus. In this context, preference is given to those peptides corresponding to segments of amino acids 505 to 647, 517 to 597, 535 to 584 or 545 to 582. The immunoreactive peptides are useful for methods of diagnosing varicella zoster virus infection.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: July 2, 2002
    Assignee: Dade Behring Marburg GmbH
    Inventors: Markus Eickmann, Dorothee Gicklhorn, Klaus Radsak, Hans-Peter Hauser, Bernhard Giesendorf
  • Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
    Patent number: 6258363
    Abstract: Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use are described. The invention relates to immunoreactive peptides which are homologous with the region of amino acid positions 12 to 235 of the varicella zoster virus protein VP26, to nucleic acids which encode these peptides and to the use of the peptides or nucleic acids for diagnosing an infection with varicella zoster virus.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: July 10, 2001
    Assignee: Dade Behring Marburg GmbH
    Inventors: Markus Eickmann, Dorothee Gicklhorn, Klaus Radsak, Hans-Peter Hauser, Bernhard Giesendorf